Technical420 Site Search

As we approach the mid-point of the year, we want to highlight some of the most significant themes in the cannabis industry that could prove to be important catalysts for the entire sector.  Going forward, we expect the market to be highly focused on these 7 themes and believe that…

After the market closed on Wednesday, Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY) filed a preliminary proxy statement with the United States (US) Securities and Exchange Commission (SEC) and we consider the filing to be significant. Two key proposals that were highlighted in the preliminary proxy statement are related to increasing…

Following the completion of a merger with Aphria, Tilray (TSX: TLRY) (Nasdaq: TLRY) has been frequently highlighted on major financial media platforms. We believe the combined company owns high-value, strategic cannabis assets in North America and the European Union (EU). Earlier this week, Tilray CEO Irwin Simon was featured on…

Tilray, Inc. (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the launch of Symbios, a complement to the Company’s existing medical brand portfolio in Canada. This new brand was developed to provide a broader spectrum of formats and unique cannabinoid ratios at a…

Following Canopy Growth’s (TSX: WEED) (Nasdaq: CGC) weaker-than-expected earning’s report, the Canadian cannabis sector has been under pressure.  During the last year, we have noticed increasing interest in emerging international cannabis markets from Canadian Licensed Producers (LPs). From the European Union (EU) to North America (Mexico and the US), leading…

Today, the United States stock market is closed in honor of memorial day and we want to take this time to discuss how the cannabis industry has advanced since last year. From North and South America to the European Union (EU), the cannabis industry is becoming a burgeoning global market,…

The cannabis sector is in the middle of earnings season and the results have been less than optimal so far.  Earlier this month, Aurora Cannabis Inc. (ACB: TSX) (ACB: NYSE) traded lower after it reported third quarter financial results that missed expectations. After reporting earnings, several broker-dealers downgraded the stock…

After leading Canadian Licensed Producers (LPs) announced quarterly financial results that came in lower than what many broker-dealers expected, several firms have issued new ratings and/or price targets on several LPs. Several of the price target decreases are substantial and we find the changes to be worth highlighting. We attribute…

Earlier this week, Tilray, Inc. (TLRY: TSX) (TLRY: Nasdaq) filed a few documents with the United States Securities and Exchange Commission (SEC) that reported a sale of more than 600,000 common shares. The stock sale is valued at more than $8.8 million and we find the transaction to be worth…

Last week, marked another milestone of the legal cannabis industry after Jazz Pharmaceuticals (Nasdaq: JAZZ) completed the acquisition of GW Pharmaceuticals plc., a leader in the science, development and commercialization of cannabinoid-based prescription medicines. Although the acquisition did receive as much attention as the merger between Aphria and Tilray, Inc. (TLRY.TO)…